Is Aptus Drawdown Managed Equity ETF (ADME) a Buy, Sell, or Hold?
CBOE : ADME
Aptus Drawdown Managed Equity ETF
$55.1708 USD
-$0.45 (-0.81%)
- Volume
- 7.9K
- Average Volume
- 14.3K
- Market Capitalization
- $287.86M
- P/E Ratio
- Dividend Yield
- %
- Price Target
- Year High
- $56.67
- Year Low
- $48.09
- Day High
- —
- Day Low
- —
- Payout Ratio
- Current Ratio
Company Overview
CBOE
Charles J. Fisher
Asset Management
Financial Services
ADME
10
US
USD
Liquidity Metrics
Sales & Valuation
-$
Profitability
-$
%
%
%
%
P/E Metrics
Analyst Price Target & Rating
0/5
0 Analysts
%
Poll Results
About Aptus Drawdown Managed Equity ETF (CBOE:ADME) Stock
ADME is an actively-managed ETF that invests in a portfolio of 50 to 60 US companies. The equity components are drawn from a universe of the 1,000 largest US-listed common stocks and REITs. For selection, the Adviser uses a proprietary framework which takes into account factors such as yield, growth, and valuation along with momentum which signifies attractive growth opportunities altogether. The Adviser seeks to limit the funds exposure to equity market declines primarily by purchasing broad market puts or ETFs tracking the US equity market. In addition, ADME may also write broad market puts and hold VIX index call options. Prior to November 8, 2019, the fund traded as the index-tracking Aptus Behavioral Momentum ETF (BEMO), and was an asset allocation utilizing risk-on/risk-off strategy ... to toggle exposure between 100% US equities and 100% Treasury notes. On December 27, 2019, the assets, liabilities and shareholders of Aptus Fortified Value ETF (FTVA) were merged into ADME.
Onco-Innovations Initiates ADME Studies Supporting Development of ONC010
2026-07-16 18:00:00
Vancouver, Canada – July 16, 2026 – TheNewswire - Onco-Innovations Limited ( CBOE CA: ONCO ) (OTCQB: ONNVF ) (Frankfurt: W1H , WKN: A3EKSZ ) (" Onco " or the " Company ”) announces, further to its news release dated May 8, 2026, the initiation of key absorption, distribution, metabolism and excretion ("ADME") studies for ONC010, the Company's lead nanoparticle-formulated Polynucleotide Kinase Phosphatase (PNKP) inhibitor. The studies are designed to characterize ONC010's pharmacokinetic and metabolic profile and support the continued IND-enabling development of the program.
2026-05-26 12:33:00
New co-developed product delivers a complete Tier 1 ADME panel coupled with best-in-class AI-driven human pharmacokinetic (PK) projection and integrated compound management —enabling scientists to make lead-optimization-quality decisions starting in hit identification BOSTON, May 26, 2026 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced that its Datapoints offering is launching ADME-One™ , a fully integrated ADME platform for drug discovery teams co-developed with Tangible Scientific and Inductive Bio . ADME-One delivers a high-throughput Tier 1 ADME (absorption, distribution, metabolism, and excretion) panel paired with best-in-class AI-powered human pharmacokinetic (PK) projection and fully integrated compound management.
Frequently Asked Questions
-
What is the current Aptus Drawdown Managed Equity ETF (ADME) stock price?
-
Aptus Drawdown Managed Equity ETF(CBOE:ADME) stock price is $55.1708 in the last trading session. During the trading session, ADME stock reached the peak price of $56.67 while $48.09 was the lowest point it dropped to. The percentage change in ADME stock occurred in the recent session was --0.81% while the dollar amount for the price change in ADME stock was -$0.45.
-
ADME's industry and sector of operation?
-
The CBOE listed ADME is part of Asset Management industry that operates in the broader Financial Services sector.
-
Who are the executives of ADME?
-
|
|
|
|
| -
How many employees does ADME have?
-
Number of ADME employees currently stands at 10. ADME operates from 314 Magnolia Avenue, Fairhope, AL 36532, US.
-
Link for ADME official website?
-
Official Website of ADME is: https://aptusetfs.com/adme
-
How do I contact ADME?
-
ADME could be contacted at phone #1-251-517-7198 and can also be accessed through its website. ADME operates from 314 Magnolia Avenue, Fairhope, AL 36532, US.
-
How many shares of ADME are traded daily?
-
The average number of ADME shares traded daily for last 3 months was 14.3K.
-
What is the market cap of ADME currently?
-
The market value of ADME currently stands at $287.86M with its latest stock price at $55.1708